Acquisition by Bayer to Broaden Innovation Base in Cell and Gene Therapy
Bayer AG announced the acquisition of Asklepios BioPharmaceutical, Inc., a US-headquartered biopharmaceutical company specialized in the research, development and manufacturing of gene therapies...